We are live on ! Find out more
BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 30 → 0 (-30)

100% less capital invested

Capital invested by funds: $135M → $0 (-$135M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 30

Holders
–
Holders Change
-30
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
WCMNY
Westchester Capital Management (New York)
New York
-$15.1M
2
WRBC
W.R. Berkley Corp
Connecticut
-$12.1M
3
FTCM
First Trust Capital Management
Illinois
-$12M
4
LA
Linden Advisors
New York
-$10.8M
5
RCM
Radcliffe Capital Management
Pennsylvania
-$7.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
ETH
26
Exos TFP Holdings
New York
– -$650K -60,000 Closed
AMC
27
Atlas Merchant Capital
New York
– -$542K -50,000 Closed
VF
28
Virtu Financial
New York
– -$221K -20,445 Closed
KIM
29
Karpus Investment Management
New York
– -$111K -10,235 Closed
CS
30
Clear Street
New York
– -$11 -1 Closed
1
2